{"schema_version":"1","generated_at":"2026-11-14T01:15:37.965Z","data_as_of":null,"url":"https://www.findmykol.com/kol/masey-ross","json_url":"https://www.findmykol.com/kol/masey-ross/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"masey-ross","name":"Masey Ross","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Virginia Commonwealth University","institution_url":"https://www.findmykol.com/institution/virginia-commonwealth-university","city":"Richmond","state":"VA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1598058133","openalex":"A5008029912"},"summary":"Masey Ross is an Oncology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 18 publications with 296 citations (h-index 4).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":18,"cited_by_count":296,"h_index":4,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":12,"shown":3,"withheld":9,"rows":[{"payer":"Genentech","program_year":2025,"amount_usd":52408,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598058133"},{"payer":"AstraZeneca","program_year":2025,"amount_usd":33780.77,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598058133"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":30.65,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598058133"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1598058133","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":73.8,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":65.1,"drugs":[{"name":"Anastrozole","share_pct":85.6},{"name":"Letrozole","share_pct":14.4}],"max_beneficiaries":null},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":8.7,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":9.4,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":9.4,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Genitourinary & hormones","share_pct":8.7,"classes_total":1,"classes":[{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":8.7,"drugs":[{"name":"Raloxifene Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":35.1,"facility_pct":64.9},"source":"medicare"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract PS1-05-24: Frequency, characterization, and clinical impact of unexpected cardiac and extracardiac imaging findings in premenopausal women on the CROWN study","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps1-05-24","status":"verified"},{"title":"Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE","year":2026,"journal":"JNCI Journal of the National Cancer Institute","source_url":"https://doi.org/10.1093/jnci/djag216","status":"verified"},{"title":"26-A-13210-ACC ELEVATED CALCIFIED CORONARY PLAQUE IN PREMENOPAUSAL WOMEN WITH TRIPLE NEGATIVE BREAST CANCER TREATED WITH IMMUNE CHECKPOINT BLOCKADE","year":2026,"journal":"Journal of the American College of Cardiology","source_url":"https://doi.org/10.1016/j.jacc.2026.02.2696","status":"verified"},{"title":"T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy","year":2025,"journal":"Journal for ImmunoTherapy of Cancer","source_url":"https://doi.org/10.1136/jitc-2024-010294","status":"verified"},{"title":"Abstract P1-09-06: Evaluation of proliferation biomarker serum thymidine kinase activity and prediction of early relapse in HR positive HER2 negative high risk early breast cancer: Analysis from the PENELOPE-B trial","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-p1-09-06","status":"verified"}],"source":"works"},"contact":{"address_1":"417 N 11TH ST","address_2":"IM RESIDENT ACC CLINIC","city":"Richmond","state":"VA","zip":"232985002","phone":"804-828-8786","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1598058133","source":"identity"},"similar":[{"name":"Jasmohan Bajaj","slug":"jasmohan-bajaj","institution":"Virginia Commonwealth University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/jasmohan-bajaj","json_url":"https://www.findmykol.com/kol/jasmohan-bajaj/profile.json"},{"name":"Patrick Ching","slug":"patrick-ching","institution":"Virginia Commonwealth University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/patrick-ching","json_url":"https://www.findmykol.com/kol/patrick-ching/profile.json"},{"name":"Bruce Rubin","slug":"bruce-rubin","institution":"Virginia Commonwealth University","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/bruce-rubin","json_url":"https://www.findmykol.com/kol/bruce-rubin/profile.json"},{"name":"Nicole Karjane","slug":"nicole-karjane","institution":"Virginia Commonwealth University","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/nicole-karjane","json_url":"https://www.findmykol.com/kol/nicole-karjane/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":9,"publications":13}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-09-11","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}